JOHNSON & JOHNSON — Director's Dealing 2024

Feb 20, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2024-02-15

Reporting Person: Schmid Timothy (EVP, WW Chair, MedTech)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-15	Employee Stock Options (Right to Buy)	$157.9200	A	49658.0000	Acquired	2034-02-15	Common Stock (49658.0000)	Direct
2024-02-15	Restricted Share Units	$	A	3085.0000	Acquired	2034-02-15	Common Stock (3085.0000)	Direct

Footnotes

F1: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

F2: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.